Mostra el registre parcial de l'element
dc.contributor.author | Eguchi, Takanori | es |
dc.contributor.author | Kanai, Ikuyo | es |
dc.contributor.author | Basugi, Akihiko | es |
dc.contributor.author | Miyata, Yukinaga | es |
dc.contributor.author | Inoue, Minako | es |
dc.contributor.author | Hamada, Yoshiki | es |
dc.date.accessioned | 2018-05-02T12:04:12Z | |
dc.date.available | 2018-05-02T12:04:12Z | |
dc.date.issued | 2017 | es |
dc.identifier.citation | Eguchi, Takanori ; Kanai, Ikuyo ; Basugi, Akihiko ; Miyata, Yukinaga ; Inoue, Minako ; Hamada, Yoshiki. The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw. En: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, 22 6 2017: 17- | es |
dc.identifier.uri | http://hdl.handle.net/10550/65949 | |
dc.description.abstract | Non-surgical treatment has generally been recommended for stage II medication-related osteonecrosis of the jaw (MRONJ) in preference to surgery. However, non-surgical treatment is not empirically effective. The aim of this study was to evaluate whether surgical or non-surgical treatment leads to better outcomes for stage II MRONJ. In this retrospective study, surgery was performed in a total of 28 patients while 24 patients underwent non-surgical treatment. The outcomes of both treatment approaches after 6 months were evaluated and statistically compared. In addition, risk factors for surgical and non-surgical treatments were assessed for each. Surgical treatment in 25 patients (89.3%) resulted in success, with failure in 3 patients (10.7%). Non-surgical treatment was successful for 8 patients (33.3%) and failed in 16 patients (66.7%). There was therefore a significant difference between surgical and non-surgical treatment outcomes (P<0.01). Regarding risk factors, in non-surgical treatment primary diseases, medications, and drug holiday had a significant effect on outcomes (P<0.01). Risk factors for surgical treatment could not be clarified. Surgical treatment is more effective than non-surgical treatment for stage II MRONJ, and drug holiday, primary disease, and medication constitute risk factors in non-surgical treatment. | es |
dc.title | The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw | es |
dc.type | journal article | es_ES |
dc.subject.unesco | UNESCO::CIENCIAS MÉDICAS | es |
dc.identifier.doi | 10.4317/medoral.22013 | es |
dc.type.hasVersion | VoR | es_ES |